Register entry
- Registered sites
- 0
- Active NDC listings
- 19
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1919 active NDC listings: 15 human otc drug, 4 drug for further processing. By marketing category: OTC MONOGRAPH DRUG 15, DRUG FOR FURTHER PROCESSING 4.
| Dosage form | NDCs |
|---|---|
| cream | 6 |
| liquid | 6 |
| lotion | 4 |
| emulsion | 1 |
| gel | 1 |
| stick | 1 |
| Route | NDCs |
|---|---|
| topical | 15 |
| Labeller name on the listing | NDCs |
|---|---|
| estee lauder inc | 19 |
Catalogue
Marketed products
19| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| DAYWEAR ADVANCED MULTI-PROTECTION ANTI-OXIDANT 24H-MOISTURE CREME BROAD SPECTRUM SPF15 | AVOBENZONE, HOMOSALATE, OCTISALATE | cream, topical | 11559-064OTC MONOGRAPH DRUG |
| DAYWEAR ANTI OXIDANT 72H-HYDRATION SORBET CREME BROAD SPECTRUM SPF 15 | AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE | cream, topical | 11559-055OTC MONOGRAPH DRUG |
| DOUBLE WEAR MAXIMUM COVER CAMOUFLAGE MAKEUP FOR FACE AND BODY BROAD SPECTRUM SPF 15 | titanium dioxide | cream, topical | 11559-030OTC MONOGRAPH DRUG |
| ESTEE LAUDER DOUBLE WEAR SHEER LONG-WEAR MAKEUP BROAD SPECTRUM SPF 19 | OCTINOXATE and TITANIUM DIOXIDE | liquid, topical | 11559-061OTC MONOGRAPH DRUG |
| ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36 | OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE | gel, topical | 11559-062OTC MONOGRAPH DRUG |
| ESTEE LAUDER MULTI-DEFENSE AQUA UV gel BROAD SPECTRUM SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | lotion, topical | 11559-060OTC MONOGRAPH DRUG |
| FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP BROAD SPECTRUM SPF 45 | ENSULIZOLE, OCTINOXATE, OCTISALATE, and ZINC OXIDE | liquid, topical | 11559-058OTC MONOGRAPH DRUG |
| FUTURIST HYDRATING COLLAGEN-PEPTIDE MAKEUP BROAD SPECTRUM SPF 20 | OCTINOXATE and TITANIUM DIOXIDE | lotion, topical | 11559-066OTC MONOGRAPH DRUG |
| FUTURIST SKIN TINT SERUM | OCTINOXATE,OCTISALATE,ZINC OXIDE | cream, topical | 11559-063OTC MONOGRAPH DRUG |
| - | OCTINOXATE and TITANIUM DIOXIDE | liquid | 11559-901DRUG FOR FURTHER PROCESSING |
| - | OCTINOXATE and TITANIUM DIOXIDE | lotion | 11559-903DRUG FOR FURTHER PROCESSING |
| PERFECTIONIST PRO MULTI-DEFENSE UV FLUID BROAD SPRECTRUM SPF 45 | TITANIUM DIOXIDE and ZINC OXIDE | lotion, topical | 11559-050OTC MONOGRAPH DRUG |
| RE-NUTRIV AGE REVERSAL VITAL RADIANCE SERUM FOUNDATION SPF 20 | OCTINOXATE and TITANIUM DIOXIDE | emulsion, topical | 11559-068OTC MONOGRAPH DRUG |
| RE-NUTRIV ULTRA RADIANCE MAKEUP BROAD SPECTRUM SPF 20 | OCTINOXATE and TITANIUM DIOXIDE | liquid, topical | 11559-057OTC MONOGRAPH DRUG |
| RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin | AVOBENZONE, OCTISALATE, and OCTOCRYLENE | cream, topical | 11559-053OTC MONOGRAPH DRUG |
| SERVE AND PRIME SUNSCREEN BROAD SPECTRUM SPF 40 | AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE | stick, topical | 11559-069OTC MONOGRAPH DRUG |
| YOUTH DEW ROLL-ON ANTIPERSPIRANT DEODORANT | ALUMINUM CHLOROHYDRATE | liquid, topical | 11559-001OTC MONOGRAPH DRUG |
| - | ensulizole, octinoxate, octisalate, and zinc oxide | liquid | 11559-900DRUG FOR FURTHER PROCESSING |
| - | octinoxate,octisalate,zinc oxide | cream | 11559-902DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing octinoxate and titanium dioxide
- Shiseido Americas Corporation1 site · 361 NDC
- CLINIQUE LABORATORIES LLC0 sites · 50 NDC
- MAX HUBER RESEARCH LAB INC0 sites · 4 NDC
Enquiry
Common questions
- Is ESTEE LAUDER INC FDA approved?
- ESTEE LAUDER INC holds no registered establishment of its own; 19 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ESTEE LAUDER INC make?
- 19 products are listed under ESTEE LAUDER INC in the openFDA NDC Directory, most often as cream; liquid; lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.